ERSTE STOCK BIOTEC EUR R01 (T)
AT0000746755
ERSTE STOCK BIOTEC EUR R01 (T)/ AT0000746755 /
| NAV04/11/2024 |
Chg.+4.0800 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
| 503.0200EUR |
+0.82% |
reinvestment |
Equity
Sector Biotechnology
|
Erste AM ▶ |
Objectif d'investissement
The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
Opérations
| Type de rendement: |
reinvestment |
| Fonds Catégorie: |
Equity |
| Pays: |
United States of America |
| Branche: |
Sector Biotechnology |
| Benchmark: |
Solactive United States Biotechnology Index NTR |
| Début de l'exercice: |
15/03 |
| Dernière distribution: |
13/06/2024 |
| Banque dépositaire: |
Erste Group Bank AG |
| Domicile: |
Austria |
| Permission de distribution: |
Austria, Germany, Czech Republic |
| Gestionnaire du fonds: |
Harald Kober, Tamas Menyhart |
| Actif net: |
226.97 Mio.
EUR
|
| Date de lancement: |
17/04/2000 |
| Focus de l'investissement: |
- |
Conditions
| Surtaxe d'émission: |
4.00% |
| Frais d'administration max.: |
1.80% |
| Investissement minimum: |
0.00 EUR |
| Deposit fees: |
- |
| Frais de rachat: |
0.00% |
| Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
| Société de fonds: |
Erste AM |
| Adresse: |
Am Belvedere 1, 1100, Wien |
| Pays: |
Austria |
| Internet: |
www.erste-am.at
|
Pays
| United States of America |
|
78.89% |
| United Kingdom |
|
9.10% |
| Netherlands |
|
3.92% |
| China |
|
1.96% |
| Denmark |
|
1.19% |
| Virgin Islands (British) |
|
1.06% |
| Bermuda |
|
1.00% |
| Canada |
|
0.85% |
| Ireland |
|
0.69% |
| Cash |
|
0.45% |
| Singapore |
|
0.34% |
| Cayman Islands |
|
0.30% |
| Belgium |
|
0.17% |
| Spain |
|
0.08% |
Branches
| Pharma/Biotechnology |
|
96.10% |
| Healthcare services |
|
3.44% |
| Cash |
|
0.45% |
| Autres |
|
0.01% |
